InsiderClue
Stocks · Health care · Pharmaceutical Preparations

uniQure N.V.

QURE Clue Score22
Fiscal year ends December CIK 0001590560 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

54
Insider
Date
Role
Action
Shares
Price
Amount
Matthew C Kapusta
2 Jul 2026
CEO, Managing Director
Sold after exercise
7,600
$45.89
$348.76K
Matthew C Kapusta
2 Jul 2026
CEO, Managing Director
Sold after exercise
4,282
$45.43
$194.53K
Matthew C Kapusta
2 Jul 2026
CEO, Managing Director
Sold after exercise
9,200
$44.43
$408.76K
Jack Kaye
30 Jun 2026
Director
Sold after exercise
17,060
$46.43
$792.10K
Jack Kaye
30 Jun 2026
Director
Sold after exercise
4,107
$46.49
$190.93K
Walid Abi-Saab
30 Jun 2026
Chief Medical Officer
Sold after exercise
20,000
$46.40
$928.00K
Walid Abi-Saab
30 Jun 2026
Chief Medical Officer
Sold after exercise
10,000
$46.46
$464.60K
Walid Abi-Saab
26 Jun 2026
Chief Medical Officer
Sell
1,434
$46.86
$67.20K
Matthew C Kapusta
25 Jun 2026
CEO, Managing Director
Sold after exercise
28,716
$50.02
$1.44M
Matthew C Kapusta
24 Jun 2026
CEO, Managing Director
Sold after exercise
6,696
$50.00
$334.80K
Matthew C Kapusta
18 Jun 2026
CEO, Managing Director
Sold after exercise
37,015
$50.00
$1.85M
Matthew C Kapusta
18 Jun 2026
CEO, Managing Director
Sold after exercise
4,656
$50.00
$232.80K
Jack Kaye
17 Jun 2026
Director
Sold after exercise
5,295
$42.57
$225.41K
Madhavan Balachandran
17 Jun 2026
Director
Sold after exercise
1,690
$42.60
$71.99K
Madhavan Balachandran
17 Jun 2026
Director
Sold after exercise
4,700
$43.66
$205.20K
Madhavan Balachandran
17 Jun 2026
Director
Sold after exercise
5,295
$47.08
$249.29K
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
11,585
$48.65
$563.61K
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
33,334
$45.01
$1.50M
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
56,929
$43.43
$2.47M
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
32,581
$45.02
$1.47M
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
6,023
$43.70
$263.21K
Matthew C Kapusta
17 Jun 2026
CEO, Managing Director
Sold after exercise
23,977
$42.61
$1.02M
Jeannette Potts
15 Jun 2026
Chief Legal Officer
Sell
5,237
$27.67
$144.91K
Madhavan Balachandran
15 Jun 2026
Director
Sold after exercise
10,000
$27.85
$278.50K
Madhavan Balachandran
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Rachelle Suzanne Jacques
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Jack Kaye
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Leonard E Post
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Jeremy P. Springhorn
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Kylie O'Keefe
11 Jun 2026
Chief Customer & Strat Officer
Sell
15,936
$27.06
$431.23K
Robert Gut
11 Jun 2026
Director
Sold on a plan
2,726
$27.06
$73.77K
David D. Meek
11 Jun 2026
Director
Sell
1,993
$27.06
$53.93K
Robert Gut
10 Jun 2026
Director
Sold after exercise
1,780
$26.05
$46.37K
Robert Gut
10 Jun 2026
Director
Sold after exercise
3,127
$26.03
$81.40K
Robert Gut
10 Jun 2026
Director
Sold after exercise
2,645
$26.07
$68.96K
Jack Kaye
3 Jun 2026
Director
Sold after exercise
2,645
$30.01
$79.38K
Walid Abi-Saab
8 May 2026
Chief Medical Officer
Sold after exercise
20,000
$25.00
$500.00K
Walid Abi-Saab
8 May 2026
Chief Medical Officer
Sold after exercise
25,000
$25.10
$627.50K
Christian Klemt
4 Mar 2026
Chief Financial Officer
Sell
12,000
$9.06
$108.72K
Jeannette Potts
4 Mar 2026
Chief Legal Officer
Sell
3,412
$9.06
$30.91K
Walid Abi-Saab
4 Mar 2026
Chief Medical Officer
Sell
808
$9.06
$7.32K
Matthew C Kapusta
4 Mar 2026
CEO, Managing Director
Sell
14,581
$9.06
$132.10K
Walid Abi-Saab
2 Mar 2026
Chief Medical Officer
Sell
1,660
$9.95
$16.52K
Jeannette Potts
2 Mar 2026
Chief Legal Officer
Sell
8,578
$9.95
$85.35K
Christian Klemt
2 Mar 2026
Chief Financial Officer
Sell
12,532
$9.95
$124.69K
Matthew C Kapusta
2 Mar 2026
CEO, Managing Director
Sell
34,437
$9.95
$342.65K
Christian Klemt
25 Feb 2026
Chief Financial Officer
Sell
6,217
$23.86
$148.34K
Matthew C Kapusta
25 Feb 2026
CEO, Managing Director
Sell
12,378
$23.86
$295.34K
Robert Gut
12 Jan 2026
Director
Sold after exercise
7,803
$25.09
$195.78K
Robert Gut
12 Jan 2026
Director
Sold after exercise
500
$25.03
$12.52K
Robert Gut
12 Jan 2026
Director
Sold after exercise
17,310
$24.39
$422.19K
Jack Kaye
9 Jan 2026
Director
Sold after exercise
6,390
$27.28
$174.32K
Robert Gut
6 Nov 2025
Director
Sold after exercise
15,594
$27.30
$425.72K
Robert Gut
6 Nov 2025
Director
Sold after exercise
15,840
$27.22
$431.16K

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 34
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 528,340
History held since 31 Jan 2017